Reviv3 Procare Company
RVIV · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Market Cap | $84,263 | $79,611 | $59,835 | $9,857 |
| - Cash | $4,770 | $3,254 | $4,833 | $374 |
| + Debt | $617 | $183 | $277 | $209 |
| Enterprise Value | $80,110 | $76,541 | $55,279 | $9,693 |
| Revenue | $0 | $27,499 | $23,521 | $2,336 |
| % Growth | -100% | 16.9% | 906.8% | – |
| Gross Profit | $18,642 | $20,194 | $17,711 | $1,508 |
| % Margin | – | 73.4% | 75.3% | 64.5% |
| EBITDA | $3,817 | $1,503 | $2,149 | -$168 |
| % Margin | – | 5.5% | 9.1% | -7.2% |
| Net Income | $0 | $0 | $1,825 | -$154 |
| % Margin | – | 0% | 7.8% | -6.6% |
| EPS Diluted | 0 | 0 | 0.1 | -0.074 |
| % Growth | – | -100% | 235.9% | – |
| Operating Cash Flow | $1,929 | $3 | $2,918 | -$126 |
| Capital Expenditures | $0 | $0 | -$66 | $0 |
| Free Cash Flow | $1,929 | $3 | $2,852 | -$126 |